FIELD: medicine, oncology, immunology. SUBSTANCE: invention relates to immunogenic composition based on TLP. Composition comprises at least one protein among TLP (Tumor Liberated Particles or particles released by tumor) or its fragment and, in part, with compositions where indicated fragments can comprise at least one of claimed peptides, given three sequences designated for treatment of cancer diseases and, in part, for treatment of non-small-cell lung cancer and urogenital system cancer in mammals. The advantage of invention involves development of novel therapeutic agents able to direct immune response for control of tumor cells. EFFECT: enhanced effectiveness of composition, valuable antitumor properties. 21 cl, 5 tbl, 2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CDCA1 PEPTIDE AND PHARMACEUTICAL DRUG CONTAINING IT | 2008 |
|
RU2486195C2 |
| POLYEPITOPE ANTI-TUMOUR VACCINE STRUCTURE CONTAINING EPITOPES OF TUMOR-ASSOCIATED ANTIGENS, PHARMACEUTICAL COMPOSITION AND ITS APPLICATION FOR STIMULATING SPECIFIC ANTI-TUMOR IMMUNE RESPONSE | 2016 |
|
RU2684235C2 |
| TTK PEPTIDES AND VACCINES CONTAINING THEM | 2010 |
|
RU2531348C2 |
| COMPOSITIONS AND METHODS FOR WT1-SPECIFIC IMMUNOTHERAPY | 1999 |
|
RU2237674C2 |
| FOXM1 PEPTIDES AND VACCINES CONTAINING THEM | 2010 |
|
RU2560431C2 |
| KNTC2 PEPTIDES AND VACCINES CONTAINING THE SAME | 2014 |
|
RU2671395C2 |
| CANCER TREATMENT USING TARGETED ANTIBODIES IN VIVO | 2011 |
|
RU2642305C2 |
| DNA COMPOSITION FOR INDUCING IMMUNE RESPONSE ON TUMOUR-ASSOCIATED MACROPHAGUES | 2007 |
|
RU2459631C2 |
| RECOMBINANT PLASMID DNA pCI-UB-POLYEPI CONTAINING EPITOPES OF TUMOUR-ASSOCIATED ANTIGENS FOR COLORECTAL CANCER AND METHOD OF ITS APPLICATION FOR STIMULATION OF SPECIFIC ANTITUMOUR IMMUNE RESPONSE AGAINST COLORECTAL CANCER CELLS | 2012 |
|
RU2507265C2 |
| METHODS FOR INCREASING EFFECTIVENESS OF ANTITUMOUR IMMUNE RESPONSE | 2015 |
|
RU2689162C2 |
